Luteolin and its derivative apigenin suppress the inducible PD-L1 expression to improve anti-tumor immunity in KRAS-mutant lung cancer
出版年份 2021 全文链接
标题
Luteolin and its derivative apigenin suppress the inducible PD-L1 expression to improve anti-tumor immunity in KRAS-mutant lung cancer
作者
关键词
Luteolin, Apigenin, KRAS, PD-L1/PD-1, Lung cancer, STAT3
出版物
CANCER LETTERS
Volume 515, Issue -, Pages 36-48
出版商
Elsevier BV
发表日期
2021-05-28
DOI
10.1016/j.canlet.2021.05.019
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- In situ antitumor vaccination: Targeting the tumor microenvironment
- (2020) Hanwen Li et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Tumor heterogeneity and clonal cooperation influence the immune selection of IFN-γ-signaling mutant cancer cells
- (2020) Jason B. Williams et al. Nature Communications
- Stroma remodeling and reduced cell division define durable response to PD-1 blockade in melanoma
- (2020) Elena Galvani et al. Nature Communications
- PD-1+ natural killer cells in human non-small cell lung cancer can be activated by PD-1/PD-L1 blockade
- (2020) Marcel P. Trefny et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Oncogenic driver genes and tumor microenvironment determine the type of liver cancer
- (2020) Gang Wang et al. Cell Death & Disease
- Dolutegravir derivative inhibits proliferation and induces apoptosis of non-small cell lung cancer cells via calcium signaling pathway
- (2020) Wen-Jun Wang et al. PHARMACOLOGICAL RESEARCH
- Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape
- (2019) Xianjie Jiang et al. Molecular Cancer
- A CD40 agonist and PD-1 antagonist antibody reprogram the microenvironment of non-immunogenic tumors to allow T cell-mediated anticancer activity
- (2019) Hayley S. Ma et al. Cancer Immunology Research
- Emerging Targeted Therapies for the Treatment of Non-small Cell Lung Cancer
- (2019) Patrick R. Halliday et al. Current Oncology Reports
- The Combination of MEK inhibitor with Immunomodulatory Antibodies Targeting PD-1 and PD-L1 Results in Prolonged Survival in Kras/p53-Driven Lung Cancer
- (2019) Jong Woo Lee et al. Journal of Thoracic Oncology
- The Therapeutic Potential of Apigenin
- (2019) Bahare Salehi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Identification of a new inhibitor of KRAS-PDEδ interaction targeting KRAS mutant nonsmall cell lung cancer
- (2019) Elaine Lai-Han Leung et al. INTERNATIONAL JOURNAL OF CANCER
- Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined Therapy
- (2019) Tuba N. Gide et al. CANCER CELL
- IL23-Producing Human Lung Cancer Cells Promote Tumor Growth via Conversion of Innate Lymphoid Cell 1 (ILC1) into ILC3
- (2019) Jaemoon Koh et al. CLINICAL CANCER RESEARCH
- Advancing Biomarker Development Through Convergent Engagement: Summary Report of the 2nd International Danube Symposium on Biomarker Development, Molecular Imaging and Applied Diagnostics; March 14–16, 2018; Vienna, Austria
- (2019) M. S. Lim et al. MOLECULAR IMAGING AND BIOLOGY
- Pulsatile MEK Inhibition Improves Anti-tumor Immunity and T Cell Function in Murine Kras Mutant Lung Cancer
- (2019) Hyejin Choi et al. Cell Reports
- Luteolin modulates gene expression related to steroidogenesis, apoptosis, and stress response in rat LC540 tumor Leydig cells
- (2019) Roxanne Couture et al. CELL BIOLOGY AND TOXICOLOGY
- circTP63 functions as a ceRNA to promote lung squamous cell carcinoma progression by upregulating FOXM1
- (2019) Zhuoan Cheng et al. Nature Communications
- Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?
- (2019) Rui-Mei Feng et al. Cancer Communications
- Role of the dynamic tumor microenvironment in controversies regarding immune checkpoint inhibitors for the treatment of non-small cell lung cancer (NSCLC) with EGFR mutations
- (2019) Anqi Lin et al. Molecular Cancer
- Niclosamide, an antihelmintic drug, enhances efficacy of PD-1/PD-L1 immune checkpoint blockade in non-small cell lung cancer
- (2019) Fan Luo et al. Journal for ImmunoTherapy of Cancer
- A Potent and Selective Small-Molecule Degrader of STAT3 Achieves Complete Tumor Regression In Vivo
- (2019) Longchuan Bai et al. CANCER CELL
- Tissue-resident memory CD8+ T cells amplify anti-tumor immunity by triggering antigen spreading through dendritic cells
- (2019) Evelyn Menares et al. Nature Communications
- Synergistic cancer immunotherapy combines MVA-CD40L induced innate and adaptive immunity with tumor targeting antibodies
- (2019) José Medina-Echeverz et al. Nature Communications
- The superior efficacy of anti-PD-1/PD-L1 immunotherapy in KRAS-mutant non-small cell lung cancer that correlates with an inflammatory phenotype and increased immunogenicity
- (2019) Chengming Liu et al. CANCER LETTERS
- The ROS-KRAS-Nrf2 axis in the control of the redox homeostasis and the intersection with survival-apoptosis pathways: Implications for photodynamic therapy
- (2019) Annalisa Ferino et al. JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY
- Antibacterial Activity of Some Flavonoids and Organic Acids Widely Distributed in Plants
- (2019) Artur Adamczak et al. Journal of Clinical Medicine
- Tumor-infiltrating B cells: their role and application in anti-tumor immunity in lung cancer
- (2018) Si-si Wang et al. Cellular & Molecular Immunology
- Interferon γ and Its Important Roles in Promoting and Inhibiting Spontaneous and Therapeutic Cancer Immunity
- (2018) Elise Alspach et al. Cold Spring Harbor Perspectives in Biology
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Plumbagin from a tropical pitcher plant (Nepenthes alata Blanco) induces apoptotic cell death via a p53-dependent pathway in MCF-7 human breast cancer cells
- (2018) Umasankar De et al. FOOD AND CHEMICAL TOXICOLOGY
- Apigenin suppresses PD-L1 expression in melanoma and host dendritic cells to elicit synergistic therapeutic effects
- (2018) Lu Xu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The Dark Side of IFN-γ: Its Role in Promoting Cancer Immunoevasion
- (2017) Marija Mojic et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity
- (2017) Marian L. Burr et al. NATURE
- MUC1-C integrates PD-L1 induction with repression of immune effectors in non-small-cell lung cancer
- (2017) A Bouillez et al. ONCOGENE
- Apigenin in cancer therapy: anti-cancer effects and mechanisms of action
- (2017) Xiaohui Yan et al. Cell and Bioscience
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Apigenin inhibits the inducible expression of programmed death ligand 1 by human and mouse mammary carcinoma cells
- (2016) Melanie R. Power Coombs et al. CANCER LETTERS
- STK11/LKB1 Deficiency Promotes Neutrophil Recruitment and Proinflammatory Cytokine Production to Suppress T-cell Activity in the Lung Tumor Microenvironment
- (2016) S. Koyama et al. CANCER RESEARCH
- Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors
- (2013) E. A. Akbay et al. Cancer Discovery
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started